1 – 21 of 21
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling
(
- Contribution to journal › Article
- 2023
-
Mark
Proteogenomics decodes the evolution of human ipsilateral breast cancer
(
- Contribution to journal › Article
-
Mark
Low levels of WRAP53 predict decreased efficacy of radiotherapy and are prognostic for local recurrence and death from breast cancer : a long-term follow-up of the SweBCG91RT randomized trial
(
- Contribution to journal › Article
-
Mark
Comparison of SP142 and 22C3 PD-L1 assays in a population-based cohort of triple-negative breast cancer patients in the context of their clinically established scoring algorithms
(
- Contribution to journal › Article
- 2022
-
Mark
A somatic mutation in moesin drives progression into acute myeloid leukemia
(
- Contribution to journal › Article
-
Mark
Histone lysine demethylase inhibition reprograms prostate cancer metabolism and mechanics
(
- Contribution to journal › Article
- 2021
-
Mark
Proteogenomic Workflow Reveals Molecular Phenotypes Related to Breast Cancer Mammographic Appearance
(
- Contribution to journal › Article
-
Mark
Regulatory interplay between mir-181a-5p and estrogen receptor signaling cascade in breast cancer
(
- Contribution to journal › Article
- 2019
-
Mark
Inhibition of histone demethylases LSD1 and UTX regulates ERα signaling in breast cancer
(
- Contribution to journal › Article
- 2017
-
Mark
Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer
(
- Contribution to journal › Article
- 2016
-
Mark
4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer
(
- Contribution to journal › Article
-
Mark
Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer
(
- Contribution to journal › Article
-
Mark
Targeted MS Assay Predicting Tamoxifen Resistance in Estrogen-Receptor-Positive Breast Cancer Tissues and Sera
(
- Contribution to journal › Article
-
Mark
The advantage of laser-capture microdissection over whole tissue analysis in proteomic profiling studies
(
- Contribution to journal › Article
-
Mark
Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer
(
- Contribution to journal › Scientific review
-
Mark
Prognostic significance of nuclear expression of UMP-CMP kinase in triple negative breast cancer patients
(
- Contribution to journal › Article
- 2015
-
Mark
Global proteomic characterization of microdissected estrogen receptor positive breast tumors
(
- Contribution to journal › Article
-
Mark
Antibody-based capture of target peptides in multiple reaction monitoring experiments
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2014
-
Mark
Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer
(
- Contribution to journal › Article
-
Mark
Ferritin heavy chain in triple negative breast cancer : a favorable prognostic marker that relates to a cluster of differentiation 8 positive (CD8+) effector T-cell response
(
- Contribution to journal › Article
- 2013
-
Mark
Quantitative proteomic analysis of microdissected breast cancer tissues : comparison of label-free and SILAC-based quantification with shotgun, directed, and targeted MS approaches
(
- Contribution to journal › Article